A forward vision for chemodynamic therapy: issues and opportunities

P Zhao, H Li, W Bu - Angewandte Chemie International Edition, 2023 - Wiley Online Library
Since the insight to fuse Fenton chemistry and nanomedicine into cancer therapy, great
signs of progress have been made in the field of chemodynamic therapy (CDT). However …

Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches

TB Emran, A Shahriar, AR Mahmud, T Rahman… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

J Zhang, CM Simpson, J Berner, HB Chong, J Fang… - Cell, 2023 - cell.com
Multiple anticancer drugs have been proposed to cause cell death, in part, by increasing the
steady-state levels of cellular reactive oxygen species (ROS). However, for most of these …

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

B Feng, J Wu, B Shen, F Jiang, J Feng - Cancer Cell International, 2022 - Springer
Cancer-associated fibroblasts (CAFs) are critical components of the tumor microenvironment
(TME) with diverse functions such as extracellular matrix (ECM) remodeling, modulation of …

Magnetic nanoparticles for cancer theranostics: Advances and prospects

X Li, W Li, M Wang, Z Liao - Journal of Controlled Release, 2021 - Elsevier
Cancer is one of the leading causes of mortality worldwide. Nanoparticles have been
broadly studied and emerged as a novel approach in diagnosis and treatment of tumors …

The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis

K Dzobo, C Dandara - Biomimetics, 2023 - mdpi.com
The extracellular matrix (ECM) is a ubiquitous member of the body and is key to the
maintenance of tissue and organ integrity. Initially thought to be a bystander in many cellular …

[HTML][HTML] Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer

J Zhai, J Shen, G Xie, J Wu, M He, L Gao, Y Zhang… - Cancer letters, 2019 - Elsevier
Chemoresistance remains the major obstacle to achieve optimal prognosis in gastric cancer
patients, and the underlying molecular mechanisms of cancer-associated fibroblasts (CAFs) …

[HTML][HTML] Emerging role of NRF2 in ROS-mediated tumor chemoresistance

D Xue, X Zhou, J Qiu - Biomedicine & pharmacotherapy, 2020 - Elsevier
Chemoresistance is a central cause for the tumor management failure. Cancer cells disrupt
the redox homeostasis through reactive oxygen species (ROS) regulatory mechanisms …

Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature

AE Guerini, L Triggiani, M Maddalo, ML Bonù… - Cancers, 2019 - mdpi.com
Anticancer treatment efficacy is limited by the development of refractory tumor cells
characterized by increased expression and activity of mechanisms promoting survival …

Interplay between mitochondrial peroxiredoxins and ROS in cancer development and progression

T Ismail, Y Kim, H Lee, DS Lee, HS Lee - International journal of …, 2019 - mdpi.com
Mitochondria are multifunctional cellular organelles that are major producers of reactive
oxygen species (ROS) in eukaryotes; to maintain the redox balance, they are supplemented …